These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27504667)

  • 1. Application of Coiled Coil Peptides in Liposomal Anticancer Drug Delivery Using a Zebrafish Xenograft Model.
    Yang J; Shimada Y; Olsthoorn RC; Snaar-Jagalska BE; Spaink HP; Kros A
    ACS Nano; 2016 Aug; 10(8):7428-35. PubMed ID: 27504667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
    Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
    J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
    Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
    Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coiled coil interactions for the targeting of liposomes for nucleic acid delivery.
    Oude Blenke EE; van den Dikkenberg J; van Kolck B; Kros A; Mastrobattista E
    Nanoscale; 2016 Apr; 8(16):8955-65. PubMed ID: 27073992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
    Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
    Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of cholesteryl doxorubicin and its anti-cancer activity.
    Choi JS; Doh KO; Kim BK; Seu YB
    Bioorg Med Chem Lett; 2017 Feb; 27(4):723-728. PubMed ID: 28129977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Liposomal Drug Delivery Via Membrane Fusion Triggered by Dimeric Coiled-Coil Peptides.
    Zeng Y; Shen M; Singhal A; Sevink GJA; Crone N; Boyle AL; Kros A
    Small; 2023 Sep; 19(37):e2301133. PubMed ID: 37199140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-Triggered Cancer Cell Specific Targeting and Liposomal Drug Delivery in a Zebrafish Xenograft Model.
    Kong L; Chen Q; Campbell F; Snaar-Jagalska E; Kros A
    Adv Healthc Mater; 2020 Mar; 9(6):e1901489. PubMed ID: 32052583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanodrug-enhanced radiofrequency tumor ablation: effect of micellar or liposomal carrier on drug delivery and treatment efficacy.
    Moussa M; Goldberg SN; Kumar G; Sawant RR; Levchenko T; Torchilin VP; Ahmed M
    PLoS One; 2014; 9(8):e102727. PubMed ID: 25133740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
    Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
    Yuan M; Qiu Y; Zhang L; Gao H; He Q
    Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
    Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery using polyhistidine peptide-modified liposomes that target endogenous lysosome.
    Hayashi T; Shinagawa M; Kawano T; Iwasaki T
    Biochem Biophys Res Commun; 2018 Jun; 501(3):648-653. PubMed ID: 29746864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
    Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
    Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes.
    Arai T; Benny O; Joki T; Menon LG; Machluf M; Abe T; Carroll RS; Black PM
    Anticancer Res; 2010 Apr; 30(4):1057-64. PubMed ID: 20530409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.
    Jiang J; Yang SJ; Wang JC; Yang LJ; Xu ZZ; Yang T; Liu XY; Zhang Q
    Eur J Pharm Biopharm; 2010 Oct; 76(2):170-8. PubMed ID: 20600887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.
    Lin W; Xie X; Yang Y; Fu X; Liu H; Yang Y; Deng J
    Drug Deliv; 2016 Nov; 23(9):3436-3443. PubMed ID: 27193383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.